Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate fromSubject ▼
 26.4.2019KRKA, d.d., Novo mesto (KRK-2)1207BLexaurin 3 mg (tbl 28x3 mg (blis.Al/PVC))23.4.2019O
 30.4.2019Zentiva, k.s. (ZNT-1)5330AEzen 10 mg (tbl 30x10 mg (blis.PVC/Aclar/PVC/Al))18.4.2019O
 26.4.2019Viatris Limited (VIM)08255Vancomycin Mylan 500 mg (plv ifo 1x500 mg (liek.inj.skl.))30.4.2019O
 26.4.2019Mylan IRE Healthcare Limited (MYR)71950Isoptin SR 240 mg (tbl plg 30x240 mg (blis.PVC/PVDC/Al))26.4.2019O
 6.5.2019Teva B.V. (TEV-NL-4)94916Ambrobene 15 mg (sol inj 5x2 ml/15 mg (liek.inj.))10.5.2019O
 12.6.2019Upjohn EESV (UPO-NL)83541ZOLOFT 100 mg (tbl flm 28x100 mg (blis.Al/PVC))13.6.2019O
 21.5.2019Mylan Ireland Limited (MNY)35237Alfuzosin Mylan 10 mg (tbl plg 90x10 mg (blis.PVC/PVDC/Al))24.5.2019O
 21.5.2019Pfizer Europe MA EEIG (PFI-BE-3)40906VFEND 40 mg/ml prášok na perorálnu suspenziu (plu por 1x45 g (40 mg/ml) (fľ.HDPE))21.5.2019O
 21.5.2019Upjohn EESV (UPO-NL)90957XANAX 0,25 mg (tbl 30x0,25 mg (blis.PVC/Al))21.5.2019O
 21.5.2019Pfizer Europe MA EEIG (PFI-BE-3)94967ACCUPRO 10 (tbl flm 100x10 mg (blis.Al/PA/Al/PVC))21.5.2019O
 21.5.2019Pfizer Europe MA EEIG (PFI-BE-3)94959ACCUPRO 10 (tbl flm 30x10 mg (blis.Al/PA/Al/PVC))21.5.2019O
 7.5.2019ratiopharm GmbH (RAT)69884Indapamid ratiopharm 1,5 mg (tbl plg 30x1,5 mg (blister PVC/PVDc/Al))17.5.2019O
 7.5.2019TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)30221Solifenacin Teva 10 mg (tbl flm 30x10 mg (blis.PVC/PVDC/Al))17.5.2019O
 3.6.2019Bayer AG (BYE-4)03134Gadovist 1,0 mmol/ ml (sol iru 5x7,5 ml (striek.inj.napl.skl.))3.6.2019O
 30.4.2019Pfizer Europe MA EEIG (PFI-BE-3)05886GENOTROPIN 12 mg (plv iol 1x12 mg (náplň inj.skl.dvojkom.+pero GoQuick))30.4.2019O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)